SMTL ID : 4enh.1

Crystal Structure of Human Cytochrome P450 CYP46A1 with Fluvoxamine Bound

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 27 residues within 4Å: Chain A: K.56, Y.61, L.77, V.78, W.86, R.90, F.97, F.251, A.254, G.255, T.258, S.259, H.262, A.319, T.322, R.324, P.381, F.382, S.383, R.387, S.388, C.389, I.390, G.391, F.394, A.395 Ligands: FVX.2 18 PLIP interactions: 18 interactions with chain A, Hydrophobic interactions: A:V.78, A:F.97, A:F.251, A:A.254, A:H.262, A:A.319, A:F.382, A:I.390, A:F.394, A:A.395 Hydrogen bonds: A:R.324, A:R.387 Water bridges: A:K.56, A:T.322 Salt bridges: A:K.56, A:R.90, A:R.387 Metal complexes: A:C.389

1 x FVX: Fluvoxamine(Non-covalent)

FVX.2: 15 residues within 4Å: Chain A: F.32, F.73, L.171, I.174, I.253, A.254, T.258, A.319, W.320, G.321, T.322, F.323, A.426, T.427 Ligands: HEM.1 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:F.73, A:T.427 Hydrogen bonds: A:T.258, A:T.258

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mast, N. et al., In Silico and Intuitive Predictions of CYP46A1 Inhibition by Marketed Drugs with Subsequent Enzyme Crystallization in Complex with Fluvoxamine. Mol.Pharmacol. (2012)

Release Date

2012-08-22

Peptides

Cholesterol 24-hydroxylase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cholesterol 24-hydroxylase

Related Entries With Identical Sequence